-
Neuromuscular Characteristics Associated with Knee Instability in Osteoarthritis and After Total Knee Replacement: A Systematic Review and Meta-Analysis -
Efficacy and Safety of Platelet-Rich Plasma in Knee Osteoarthritis: Umbrella Meta-Analysis Based on Clinical Evidence, Methodological Quality and Therapeutic Positioning -
Hormonal Treatments in Pediatric Growth Disorders: Effectiveness and Safety
Journal Description
Clinics and Practice
Clinics and Practice
is an international, peer-reviewed, open access journal on clinical medicine, published monthly online by MDPI (from Volume 11, Issue 1 - 2021).
- Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
- High Visibility: indexed within Scopus, ESCI (Web of Science), PubMed, PMC, Embase, and other databases.
- Journal Rank: JCR - Q1 (Medicine, General and Internal) / CiteScore - Q1 (General Medicine)
- Rapid Publication: manuscripts are peer-reviewed and a first decision is provided to authors approximately 24 days after submission; acceptance to publication is undertaken in 2.8 days (median values for papers published in this journal in the first half of 2026).
- Recognition of Reviewers: APC discount vouchers, optional signed peer review, and reviewer names published annually in the journal.
Impact Factor:
2.8 (2025);
5-Year Impact Factor:
2.4 (2025)
Latest Articles
Severe Dengue and Dengue–Malaria Coinfection: A Case Series from a Referral Hospital in Montería, Colombia
Clin. Pract. 2026, 16(8), 150; https://doi.org/10.3390/clinpract16080150 (registering DOI) - 15 Aug 2026
Abstract
►
Show Figures
Background/Objectives: Severe dengue and dengue–malaria coinfection represent major diagnostic and therapeutic challenges in tropical endemic settings, where overlapping clinical manifestations may delay recognition of deterioration. This study aimed to describe the clinical and epidemiological characteristics of patients with severe dengue, dengue with warning
[...] Read more.
Background/Objectives: Severe dengue and dengue–malaria coinfection represent major diagnostic and therapeutic challenges in tropical endemic settings, where overlapping clinical manifestations may delay recognition of deterioration. This study aimed to describe the clinical and epidemiological characteristics of patients with severe dengue, dengue with warning signs, and dengue–malaria coinfection treated at a referral hospital in Montería, Córdoba, Colombia. Methods: A retrospective case series was conducted by reviewing medical records of patients diagnosed with dengue between 2018 and 2023. Cases classified as dengue without warning signs were excluded. The final analysis included patients with dengue-warning signs, severe dengue, and dengue–malaria coinfection. Dengue classification followed the 2009 World Health Organization criteria, and malaria was confirmed by thick blood smear. Sociodemographic, clinical, laboratory, geographic, and outcome-related variables were collected. Descriptive analyses were performed, and selected categorical variables were compared using Fisher’s exact test. Results: Fifty-three patients were included: 25 (47.17%) with severe dengue, 14 (26.42%) with dengue with warning signs, and 14 (26.42%) with dengue–malaria coinfection. Severe dengue was more frequent among females, whereas dengue with warning signs and coinfection predominated in males. Children accounted for the highest proportion of severe dengue cases, while coinfected cases were mainly distributed between childhood and adolescence. Fever was documented in all patients. Edema, elevated hematocrit, severe plasma leakage, and hemodynamic compromise were more frequent among severe dengue cases, whereas myalgia differed significantly across clinical groups. Ten deaths were recorded, six occurring in coinfected patients. Conclusions: Severe dengue and dengue–malaria coinfection are clinically complex conditions with overlapping manifestations and potentially fatal outcomes, highlighting the need for early recognition, differential diagnosis, and close monitoring.
Full article
Open AccessArticle
Development and Preliminary Assessment of a Mortality Risk Score in Patients with Coronary Artery Disease Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
by
Friba Nurmukhammad, Sholpan Zhangelova, Akhmetzhan Sugraliyev, Alexander Arutyunov, Yermagambet Kuatbayev, Zhanetta Mukanova and Dina Kapsultanova
Clin. Pract. 2026, 16(8), 149; https://doi.org/10.3390/clinpract16080149 - 14 Aug 2026
Abstract
Background: Patients with coronary artery disease (CAD) receiving dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) remain at risk of early adverse outcomes, including in-hospital mortality. Simple risk stratification based on routinely available variables may help identify higher-risk patients, but a
[...] Read more.
Background: Patients with coronary artery disease (CAD) receiving dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) remain at risk of early adverse outcomes, including in-hospital mortality. Simple risk stratification based on routinely available variables may help identify higher-risk patients, but a limited number of outcome events constrains robust prediction-model development and validation. Aim: This exploratory study aimed to derive a preliminary, interpretable clinical score based on routinely available variables for risk stratification of all-cause in-hospital mortality in CAD patients receiving DAPT after PCI. In the clopidogrel-dominant practice setting of the participating centers, the score was conceived as a hypothesis-generating risk-enrichment framework rather than a validated treatment-selection tool or a surrogate measure of platelet reactivity. Methods: We analyzed a retrospective cohort of 1600 adults with CAD admitted between 2022 and 2024; 36 in-hospital deaths occurred. Twenty demographic, clinical, laboratory, and instrumental variables were evaluated. The primary outcome was all-cause in-hospital mortality during the index hospitalization. For exploratory score derivation, the dataset was randomly divided into a derivation subset (75%; n = 1200) and a hold-out assessment subset (25%; n = 400). Predictors were explored using univariable and multivariable logistic regression with stepwise selection. Continuous variables were categorized using Weight of Evidence binning, and an integer point score was derived. Performance was summarized using ROC analysis, AUC, sensitivity, specificity, and accuracy. Given the small number of deaths and the data-driven modelling workflow, all performance estimates were considered preliminary rather than definitive internal validation. Results: The exploratory six-variable score included age ≥ 57 years, estimated glomerular filtration rate < 45 mL/min/1.73 m2, body mass index ≥ 25 kg/m2, troponin I ≥ 100, prior myocardial infarction, and current smoking. In the derivation subset, each additional point was associated with higher odds of mortality (OR 1.39; 95% CI 1.29–1.51; p < 0.001), and the AUC was 0.654. A Youden-index threshold of approximately 6 points yielded sensitivity of 0.41, specificity of 0.80, and accuracy of 0.72. In the hold-out assessment subset, sensitivity was 0.53, specificity was 0.70, accuracy was 0.70, and AUC was 0.61. These estimates indicate modest discrimination and should be interpreted cautiously because only 36 outcome events were available. Conclusions: This exploratory clinical score showed modest discrimination for all-cause in-hospital mortality and should be regarded as a preliminary, hypothesis-generating risk-stratification approach. It is not sufficiently validated for routine prognostic classification, platelet-reactivity triage, or antiplatelet treatment selection. Model redevelopment using event-efficient methods, resampling-based internal validation, and subsequent external validation are required before clinical implementation.
Full article
(This article belongs to the Section Cardiac and Cardiovascular Systems)
►▼
Show Figures

Figure 1
Open AccessArticle
Calcaneal Insufficiency Fracture: An Underrecognized Cause of Atraumatic Heel Pain in Older Adults
by
Koji Nozaka and Naohisa Miyakoshi
Clin. Pract. 2026, 16(8), 148; https://doi.org/10.3390/clinpract16080148 - 13 Aug 2026
Abstract
►▼
Show Figures
Background/Objectives: Calcaneal insufficiency fractures may be overlooked in older adults presenting with atraumatic heel-region pain because early radiographic findings can be absent or inconclusive. Evidence regarding how often these fractures are identified in routine outpatient practice remains limited. This study aimed to
[...] Read more.
Background/Objectives: Calcaneal insufficiency fractures may be overlooked in older adults presenting with atraumatic heel-region pain because early radiographic findings can be absent or inconclusive. Evidence regarding how often these fractures are identified in routine outpatient practice remains limited. This study aimed to describe the observed frequency, diagnostic pathway, clinical characteristics, treatment, and documented clinical course of calcaneal insufficiency fractures in an orthopaedic outpatient cohort. Methods: We retrospectively reviewed consecutive patients aged 60 years or older who presented with atraumatic pain localised to the heel or calcaneal region between April 2012 and March 2020. All patients underwent initial plain radiography. Follow-up radiography and MRI were performed selectively when weight-bearing heel pain persisted, radiographic findings remained negative or equivocal, and clinical suspicion of an occult fracture remained. Observed fracture frequencies and exact 95% confidence intervals (CIs) were calculated. Results: Among 123 included patients, calcaneal insufficiency fractures were identified in 10, corresponding to an observed frequency of 8.1% (95% CI, 4.0–14.4%). Among 89 independently ambulatory patients, 9 fractures were identified, corresponding to an observed subgroup frequency of 10.1% (95% CI, 4.7–18.3%). These subgroup findings were descriptive and were not adjusted for potential confounders. All 10 fracture cases occurred in women, with a mean age of 78.4 years. Osteoporosis was newly identified in all fracture cases; the mean femoral-neck T-score was −3.42. Four fractures were identified on radiographic findings, whereas six required MRI to establish the diagnosis after radiographs remained negative or inconclusive. All cases were managed non-operatively. The mean interval from symptom onset to the first documented clinical improvement or resolution of heel pain was 28.4 days, and no displacement or subsequent surgical intervention was documented during the available follow-up. Conclusions: In this retrospective single-centre cohort, calcaneal insufficiency fractures were identified in a subset of older adults presenting with atraumatic heel-region pain. The observed frequencies should be interpreted as descriptive estimates rather than population prevalence figures. Calcaneal insufficiency fracture may be considered when focal heel pain persists despite normal or equivocal initial radiographs, with repeat radiography and MRI considered according to the clinical context. Prospective studies using standardised imaging and follow-up protocols are needed.
Full article

Figure 1
Open AccessReview
Vitamin D and Postpartum Depression: A Narrative Review
by
Afra Almashghouni, Haydar Hasan and Dimitrios Papandreou
Clin. Pract. 2026, 16(8), 147; https://doi.org/10.3390/clinpract16080147 - 8 Aug 2026
Abstract
►▼
Show Figures
Background/objective: Postpartum depression (PPD) is a significant public health issue affecting about 19% of mothers globally. It has well-documented impacts on maternal well-being, mother–infant relationships, and child developmental outcomes. At the same time, the level of vitamin D deficiency in women of reproductive
[...] Read more.
Background/objective: Postpartum depression (PPD) is a significant public health issue affecting about 19% of mothers globally. It has well-documented impacts on maternal well-being, mother–infant relationships, and child developmental outcomes. At the same time, the level of vitamin D deficiency in women of reproductive age is very high (affecting 60–87 percent of pregnant women globally). The review aims to synthesize current evidence and highlight priority research areas to improve maternal mental health outcomes. Methods: A systematic literature search of PubMed, Scopus, and Google Scholar (2015–2026) was conducted, followed by narrative synthesis of mechanistic, observational, and interventional evidence. Results: Adequate vitamin D status may contribute to a reduced risk of postpartum depression through multiple interacting pathways, including serotonin synthesis and metabolism (via tryptophan hydroxylase 2 (TPH2) and monoamine oxidase-A (MAO-A) regulation), neuroplasticity via brain-derived neurotrophic factor (BDNF) signaling, and suppression of the pro-inflammatory cytokine cascade. Dose–response meta-analyses and large prospective cohort studies indicate consistent negative relationships between maternal vitamin D levels and postpartum depressive and anxiety symptoms with optimal serum 25-hydroxyvitamin D (25(OH)D) levels of 90–110 nmol/L. Conclusions: There is still limited evidence on the intervention; it is still methodologically diverse, and only a few randomized controlled trials have been carried out on specifically postpartum populations.
Full article

Figure 1
Open AccessArticle
Guselkumab Every 4 Weeks as a Real-World Therapeutic Option for Psoriatic Arthritis Patients at High Risk of Joint Damage
by
Nicoletta Bernardini, Giorgio Marotta, Nevena Skroza, Dario Graceffa, Maria Consiglia Bragazzi, Lucia Finistauri Guacci, Ersilia Tolino, Francesca Paola Sasso, Umberto Gallo, Antonio Giovanni Richetta and Annunziata Dattola
Clin. Pract. 2026, 16(8), 146; https://doi.org/10.3390/clinpract16080146 - 7 Aug 2026
Abstract
►▼
Show Figures
Background: Guselkumab, a monoclonal antibody selectively targeting the p19 subunit of interleukin-23, is typically administered with an induction phase at weeks 0 and 4 followed by maintenance dosing every 8 weeks for the treatment of psoriatic arthritis (PsA). In Europe, a four-week regimen
[...] Read more.
Background: Guselkumab, a monoclonal antibody selectively targeting the p19 subunit of interleukin-23, is typically administered with an induction phase at weeks 0 and 4 followed by maintenance dosing every 8 weeks for the treatment of psoriatic arthritis (PsA). In Europe, a four-week regimen (Q4W) has recently been approved for patients at high risk of joint damage progression; however, real-world evidence on this intensified schedule remains limited. This study aimed to evaluate the effectiveness and safety of guselkumab Q4W in routine clinical practice. Methods: This retrospective observational study included 18 PsA patients at high risk of structural damage treated with guselkumab Q4W at two psoriasis referral centers in the Lazio region of Italy. Baseline and 24-week clinical data were collected from medical records. Outcome measures included Disease Activity Index for Psoriatic Arthritis (DAPSA), Minimal Disease Activity (MDA), pain Visual Analog Scale (VAS), Dermatology Life Quality Index (DLQI), and Psoriasis Area and Severity Index (PASI). Results: After 24 weeks, mean DAPSA decreased from 34.3 ± 7.6 to 3.7 ± 3.0; 55.6% of patients achieved DAPSA remission and 77.8% achieved MDA. Significant improvements were observed in pain VAS, DLQI, and PASI scores. All patients achieved PASI 75, while 83.3% achieved PASI 90 and PASI 100. Treatment was generally well tolerated, with no adverse events or new safety signals documented during follow-up. Conclusions: In our study, guselkumab Q4W showed marked multidomain effectiveness and a favorable safety profile, supporting its use in PsA patients at high risk of joint damage progression.
Full article

Figure 1
Open AccessArticle
Glycemic Status and Glycemic Variability Related to Mortality and Morbidity in Critically III Diabetic and Non-Diabetic Patients: A Prospective Observational Study
by
Mădălina Diana Fehér, Codrin Dan Nicolae Ilea, Cosmin Mihai Vesa, Alina Cristiana Venter, Simona Daciana Birsan, Timea Claudia Ghitea, Rareș Cristian Daina, László Fehér and Cristian Marius Daina
Clin. Pract. 2026, 16(8), 145; https://doi.org/10.3390/clinpract16080145 - 6 Aug 2026
Abstract
►▼
Show Figures
Background: Glycemic dysregulation is frequent in critically ill patients and may influence prognosis regardless of pre-existing diabetes status. This study aimed to evaluate the impact of glycemic status and glycemic variability on mortality and morbidity in diabetic and non-diabetic patients admitted to the
[...] Read more.
Background: Glycemic dysregulation is frequent in critically ill patients and may influence prognosis regardless of pre-existing diabetes status. This study aimed to evaluate the impact of glycemic status and glycemic variability on mortality and morbidity in diabetic and non-diabetic patients admitted to the intensive care unit (ICU). Methods: This prospective observational study included 244 critically ill patients. Demographic, clinical, biological, and glycemic data were collected during ICU hospitalization. Glycemic parameters included admission glucose, mean glucose, glucose standard deviation, coefficient of glycemic variability, hyperglycemia > 140 mg/dL, hyperglycemia > 180 mg/dL, hypoglycemia < 70 mg/dL, and intravenous insulin requirement. The primary outcome was in-hospital mortality. Results: In-hospital mortality was 58.6%. Non-survivors had significantly higher admission glucose, mean glucose, glycemic standard deviation, and coefficient of glycemic variability compared with survivors. Hyperglycemia > 140 mg/dL, hyperglycemia > 180 mg/dL, poor glycemic control, and intravenous insulin therapy were significantly associated with mortality. Patients with high glycemic variability, defined as coefficient of variation (CV) > 36%, had higher mortality than those with lower variability. In multivariable analysis, mean glucose remained the most robust glycemic predictor associated with mortality, while glycemic variability retained prognostic relevance in alternative models. Conclusions: Glycemic dysregulation was common and clinically relevant in critically ill diabetic and non-diabetic patients. Dynamic glucose monitoring, including mean glucose and glycemic variability, may improve risk stratification and support structured ICU glycemic management.
Full article

Figure 1
Open AccessCase Report
Mediastinal Lymphangioma of the Adult: Case Report and Literature Review
by
Mihaela-Beatrice Tivadar, Amir-Andrei Sabha, Vasile Grigorie, Raluca Bobocea and Andrei-Cristian Bobocea
Clin. Pract. 2026, 16(8), 144; https://doi.org/10.3390/clinpract16080144 - 6 Aug 2026
Abstract
►▼
Show Figures
Introduction: Mediastinal lymphangiomas are rare, benign vascular malformations of the lymphatic system that are seldom diagnosed in adults. Due to their varied clinical presentation and heterogeneous imaging characteristics, they pose a significant preoperative diagnostic challenge, frequently mimicking other mediastinal masses. Materials and
[...] Read more.
Introduction: Mediastinal lymphangiomas are rare, benign vascular malformations of the lymphatic system that are seldom diagnosed in adults. Due to their varied clinical presentation and heterogeneous imaging characteristics, they pose a significant preoperative diagnostic challenge, frequently mimicking other mediastinal masses. Materials and Methods: We conducted a thorough search of the PubMed/MEDLINE, PubMed Central, and Google Scholar databases. We included articles from 2000 to 2026. Our search yielded 150 articles, out of which we selected 45 articles. Inclusion criteria were strictly limited to adult patients with a solitary mediastinal lymphangioma. Cases involving diffuse systemic lymphangiomatosis, mixed histological features such as lymphangiomyomas or hemangiolymphangioma or studies on pediatric populations were explicitly excluded from the analysis. We also reported a case of mediastinal lymphangioma in a 42-year-old patient, which was surgically resected at the “Marius Nasta” National Institute of Pneumology in Bucharest, Romania. Case Description: An asymptomatic 42-year-old male presenting with exertional chest discomfort following minor trauma demonstrated a lower left hemithorax opacity on chest X-ray. Imagistic studies revealed a 13 × 9 × 6 cm cystic mass in the left supradiaphragmatic costophrenic recess. The patient underwent a complete radical excision. The postoperative recovery was uneventful. Histopathology confirmed a benign cystic mediastinal lymphangioma. Conclusions: Adult mediastinal lymphangiomas are rare entities that require a high index of clinical suspicion. While advanced cross-sectional imaging is invaluable for delineating their characteristics, definitive diagnosis relies on histopathological confirmation. Complete surgical resection, increasingly performed via minimally invasive approaches or standard thoracotomy, remains the therapeutic gold standard, offering an excellent long-term prognosis with virtually no risk of recurrence. For inoperable cases, several non-surgical approaches are available.
Full article

Figure 1
Open AccessArticle
A Multidomain Prediction Model Integrating Myocardial Injury, Ventricular Function, and Inflammation for Short-Term Risk Stratification in Patients with NSTEMI
by
Emir Bećirović, Minela Bećirović, Amir Bećirović, Amir Tursunović, Ajla Bajrić, Amil Softić, Adna Mujkić, Elma Mujaković, Admir Abdić and Lamija Ferhatbegović
Clin. Pract. 2026, 16(8), 143; https://doi.org/10.3390/clinpract16080143 - 4 Aug 2026
Abstract
Background/Objectives: Early risk stratification remains challenging in patients with non-ST-segment elevation myocardial infarction (NSTEMI). The present study evaluated the prognostic value of 24 h high-sensitivity cardiac troponin I (hs-Troponin I) and assessed whether combining biomarkers and echocardiographic parameters improves short-term risk prediction.
[...] Read more.
Background/Objectives: Early risk stratification remains challenging in patients with non-ST-segment elevation myocardial infarction (NSTEMI). The present study evaluated the prognostic value of 24 h high-sensitivity cardiac troponin I (hs-Troponin I) and assessed whether combining biomarkers and echocardiographic parameters improves short-term risk prediction. Methods: This prospective observational cohort study included 170 consecutive adult patients with confirmed NSTEMI who were admitted to a Medical Intensive Care Unit and prospectively enrolled between February 2022 and January 2023. Clinical, routine biochemical, inflammatory, hematological, lipid, and echocardiographic data were collected during index hospitalization. High-sensitivity cardiac troponin I was measured at admission and again 24 h after hospitalization, with the 24 h value used as the principal marker of myocardial injury in the prediction analyses. The primary endpoint was major adverse cardiovascular events (MACEs), defined as cardiovascular death, recurrent myocardial infarction, ischemic stroke, urgent coronary revascularization, or hospitalization for worsening heart failure, within 3 months. Multivariable logistic regression, Cox regression, sequential prediction modeling, and internal bootstrap validation were performed. Results: MACEs occurred in 88 patients (51.8%). Twenty-four-hour hs-Troponin I, but not admission hs-Troponin I, was independently associated with MACEs (OR 1.57, 95% CI 1.09–2.26; p = 0.015) and a shorter time to the first MACE event (HR 1.38, 95% CI 1.07–1.78; p = 0.012). Lower left ventricular ejection fraction (LVEF) was also independently associated with adverse outcomes. The addition of 24 h hs-Troponin I, LVEF, and C-reactive protein improved discrimination from an AUC of 0.665 to 0.759 (optimism-corrected AUC, 0.717), with corresponding improvements in reclassification. A simplified multimarker score was independently associated with event-free survival (HR 2.36, 95% CI 1.53–3.64; p < 0.001). Conclusions: In patients admitted to a medical intensive care unit with NSTEMI, the integration of 24 h hs-Troponin I, LVEF, and C-reactive protein improved short-term risk prediction beyond that of clinical variables alone. A practical multimarker model based on routinely available parameters identified patients at increased risk of adverse cardiovascular outcomes during early follow-up.
Full article
(This article belongs to the Section Cardiac and Cardiovascular Systems)
►▼
Show Figures

Figure 1
Open AccessArticle
Reproducibility of Mandibular Cortical Index Classification Among Dental Examiners and a Single Generative AI Platform: An Observer Agreement Study
by
Keisuke Seki, Minori Kashima, Taiki Akiyama, Atsushi Kobayashi, Ko Dezawa, Yoshimasa Takeuchi, Mika Furuchi and Atsushi Kamimoto
Clin. Pract. 2026, 16(8), 142; https://doi.org/10.3390/clinpract16080142 - 31 Jul 2026
Abstract
Background/Objectives: The mandibular cortical index (MCI) is a valuable screening tool for osteoporosis on dental panoramic radiographs, but its assessment is subject to inter-examiner variability. This study evaluated the reproducibility and inter-rater agreement of MCI classification by a closed-source generative AI tool (NotebookLM,
[...] Read more.
Background/Objectives: The mandibular cortical index (MCI) is a valuable screening tool for osteoporosis on dental panoramic radiographs, but its assessment is subject to inter-examiner variability. This study evaluated the reproducibility and inter-rater agreement of MCI classification by a closed-source generative AI tool (NotebookLM, Google) compared with eight dentists of varying clinical experience. Methods: One hundred panoramic radiographs were classified according to the three-category MCI in two sessions held at least two weeks apart. Intra-examiner reliability, inter-examiner agreement, and agreement with a reference radiologist were assessed using linearly weighted kappa coefficients. The study was designed as a descriptive reliability study rather than a formal equivalence trial. Results: The intra-examiner reliability of the AI was exceptionally high (κ = 0.987). However, agreement between the AI and the dentists remained at “slight agreement” or lower (κ < 0.2) for every pairing, with 95% confidence intervals that included zero; no formal global hypothesis test was performed, and these individual interval estimates should not be interpreted as proof of the absence of agreement beyond chance. A “two-level discrepancy,” in which the AI interchanged Class 1 (normal) and Class 3 (severe), occurred in 10–18% of cases. The dentists showed a possible learning effect, with inter-examiner agreement improving between sessions. Conclusions: Despite the high reproducibility of the NotebookLM configuration evaluated in this study, agreement with the dentists remained at “slight” or lower (κ < 0.2) in MCI classification. As classifications were not validated against bone mineral density or an adjudicated reference standard, these findings concern reproducibility and agreement rather than diagnostic or screening performance and characterize a single LLM-based platform rather than generative AI in general.
Full article
(This article belongs to the Topic Artificial Intelligence in Public Health: Current Trends and Future Possibilities, 3rd Edition)
►▼
Show Figures

Figure 1
Open AccessArticle
Myoprotective Fat-Loss Phenotypes in Obesity-Associated Type 2 Diabetes: A 12-Month Real-World Cohort Study of Metformin-Based Treatment Regimens
by
Ioana Bujdei-Tebeică, Anca Mihaela Pantea-Stoian, Doina Andrada Mihai, Simona Diana Ștefan and Cristian Serafinceanu
Clin. Pract. 2026, 16(8), 141; https://doi.org/10.3390/clinpract16080141 - 28 Jul 2026
Abstract
►▼
Show Figures
Background/Objectives: In obesity-associated type 2 diabetes (T2DM), therapeutic benefit increasingly requires assessment of not only HbA1c and total body weight, but also the composition and functional quality of weight change. We evaluated a myoprotective fat-loss phenotype, defined as a reduction in adiposity
[...] Read more.
Background/Objectives: In obesity-associated type 2 diabetes (T2DM), therapeutic benefit increasingly requires assessment of not only HbA1c and total body weight, but also the composition and functional quality of weight change. We evaluated a myoprotective fat-loss phenotype, defined as a reduction in adiposity accompanied by preservation of lean mass and handgrip strength. Methods: This secondary patient-level analysis included 166 adults with T2DM who completed 12 months of follow-up without changing treatment in a real-world tertiary diabetes cohort. Patients received metformin alone or metformin combined with a sulfonylurea, a DPP-4 inhibitor, an SGLT2 inhibitor, a GLP-1 receptor agonist, or insulin. Body composition was assessed by bioimpedance and muscle function by handgrip dynamometry. The primary phenotype required a reduction in fat mass ≥5%, a loss of lean mass <3%, and a decrease in handgrip ≤1 kg. Phenotype distributions were compared between treatment groups; patient-level associations and adjusted contrasts were explored using correlation analyses and baseline-adjusted regression models with robust HC3 standard errors. Results: Fat-mass reduction ≥5% occurred in 58/166 patients (34.9%), lean-mass preservation in 129/166 (77.7%), and handgrip preservation in 143/166 (86.1%). The complete myoprotective phenotype was present in 35/166 patients (21.1%) and differed significantly across treatment groups (χ2 = 131.58; permutation p < 0.0001). It was most frequent in the GLP-1 receptor agonist group (13/23; 56.5%) and the SGLT2 inhibitor group (12/25; 48.0%), less frequent with metformin monotherapy (9/46; 19.6%) and DPP-4 inhibitors (1/17; 5.9%), and absent in the sulfonylurea and insulin groups. GLP-1 receptor agonists showed the greatest crude fat-mass loss, whereas lean-mass loss, skeletal-muscle-mass change, and handgrip change did not differ significantly across groups after false-discovery-rate correction. Conclusions: Myoprotective fat-loss phenotypes can be identified in obesity-associated T2DM using body composition and handgrip measures. These observational findings support the assessment of the quality, not just the magnitude, of weight loss in diabetes care and require validation in larger prospective studies.
Full article

Figure 1
Open AccessReview
The Interplay of Quality of Life and Satisfaction with Nursing Care in Cancer Patients: A Narrative Review
by
Efthymia Vlachothanasi, Ioanna Tsatsou, Theocharis I. Konstantinidis, Maria Saridi, Evangelos C. Fradelos, Georgios Goumas and Pavlos Sarafis
Clin. Pract. 2026, 16(8), 140; https://doi.org/10.3390/clinpract16080140 - 27 Jul 2026
Abstract
►▼
Show Figures
This narrative review explores the interconnected relationship between quality of life (QoL) and satisfaction with nursing care (SNC) among cancer patients, recognizing that cancer’s burden extends beyond survival and significantly affects physical, psychological, and social well-being. A non-systematic search of PubMed, CINAHL, Scopus,
[...] Read more.
This narrative review explores the interconnected relationship between quality of life (QoL) and satisfaction with nursing care (SNC) among cancer patients, recognizing that cancer’s burden extends beyond survival and significantly affects physical, psychological, and social well-being. A non-systematic search of PubMed, CINAHL, Scopus, and Google Scholar (2000–2025) identified relevant literature using keywords related to oncology nursing, QoL, SNC and patient satisfaction. Inclusion criteria encompassed peer-reviewed studies (quantitative, qualitative, and reviews) involving adult cancer populations and validated assessment instruments. Pediatric and non-nursing studies were excluded. Both QoL and SNC are critical outcomes in cancer care. QoL is an individual’s subjective perception and SNC reflects the patient’s subjective evaluation of how well nursing services align with their expectations, encompassing empathy, competence, and responsiveness. Research consistently demonstrates a strong positive association between high SNC and superior QoL outcomes, particularly through effective pain and symptom management, reducing psychological distress, and fostering patient empowerment. This relationship, however, is moderated by factors such as the patient’s disease stage, the type of care (hospital vs. palliative/home care), and organizational deficits like high nurse workload, which can undermine the delivery of high-quality care. Ultimately, ethical nursing practices are crucial for translating professional duty into positive patient experiences that are favorably linked with both SNC and QoL outcomes for cancer patients.
Full article

Figure 1
Open AccessArticle
Optimal Timing for Intrauterine Device Insertion During the Menstrual Cycle: A Comparative Study of Pain, Bleeding, and Postprocedural Outcomes
by
Lucian Șerbănescu, Sebastian Mirea, Vadym Rotar, Ștefan-Adrian Vrîncianu, Elena Mocanu, Maria Fulina, Stere Popescu, Cosmin Nișcoveanu and Radu-Andrei Baz
Clin. Pract. 2026, 16(8), 139; https://doi.org/10.3390/clinpract16080139 - 27 Jul 2026
Abstract
Background: Intrauterine device (IUD) insertion is a highly effective contraceptive procedure but is frequently associated with pain and bleeding, which may negatively influence patient acceptance and continuation rates. Although traditionally performed during menstruation, the optimal timing of insertion within the menstrual cycle remains
[...] Read more.
Background: Intrauterine device (IUD) insertion is a highly effective contraceptive procedure but is frequently associated with pain and bleeding, which may negatively influence patient acceptance and continuation rates. Although traditionally performed during menstruation, the optimal timing of insertion within the menstrual cycle remains uncertain, with limited data regarding patient-centered outcomes. Objective: The aim of this study was to evaluate the impact of menstrual cycle timing on pain, intra-procedural bleeding, and postprocedural outcomes in women undergoing IUD insertion. Methods: A comparative observational study was conducted including 200 parous women aged 20–40 years. Participants were consecutively enrolled and classified into two groups according to the day of the menstrual cycle at presentation for IUD insertion: Group A (days 3–7 of the menstrual cycle) and Group B (days 10–14). All procedures were performed by the same experienced gynecologist using a standardized technique. Pain was assessed using a Visual Analog Scale (VAS), intra-procedural bleeding was graded on a 0–3 scale, and postprocedural outcomes included analgesic use and bleeding characteristics. Statistical analysis was performed using independent t-tests and chi-square tests. Results: Baseline characteristics were comparable between groups (p > 0.05). Mean pain scores were significantly lower in Group B compared to Group A (3.1 ± 1.2 vs. 5.8 ± 1.4, p < 0.001). Intra-procedural bleeding was also significantly reduced in the mid-cycle group, with higher rates of minimal or no bleeding (85% vs. 20%, p < 0.001). The need for postprocedural anti-inflammatory medication was significantly lower in Group B (22% vs. 76%, p < 0.001). Additionally, postprocedural bleeding duration and intensity were reduced in the mid-cycle group. Conclusions: IUD insertion performed during the mid-cycle phase was associated with significantly better tolerability, including reduced pain, less bleeding, and decreased need for analgesia. While current guidelines allow flexible timing, these findings suggest that mid-cycle insertion may be associated with improved patient comfort when clinically feasible to improve patient experience without compromising access to contraception. Further randomized studies are warranted to confirm these results.
Full article
(This article belongs to the Section Reproductive Medicine and Women’s Health)
Open AccessPerspective
Bringing the Line Home: A Perspective on Establishing At-Home PICC (Peripherally Inserted Central Catheter) Insertion in Oncology Patients
by
Orestis Ioannidis, Antonia Aikaterini Bourtzinakou, Elissavet Anestiadou, Evangelia Ioannidou, Konstantinos Siozos, Georgios Gemousakakis, Stefanos Bitsianis, Savvas Symeonidis, Efstathios Kotidis, Manousos Georgios Pramateftakis, Ioannis Mantzoros and Stamatios Angelopoulos
Clin. Pract. 2026, 16(8), 138; https://doi.org/10.3390/clinpract16080138 - 27 Jul 2026
Abstract
Background and Objectives: Vascular access in cancer patients with limited mobility remains a persistent clinical challenge, although both devices and insertion methods have improved considerably. We present our clinical experience with at-home PICC placement, supported by real-world data from routine practice, in oncology
[...] Read more.
Background and Objectives: Vascular access in cancer patients with limited mobility remains a persistent clinical challenge, although both devices and insertion methods have improved considerably. We present our clinical experience with at-home PICC placement, supported by real-world data from routine practice, in oncology patients unable to attend hospital care, exploring its feasibility, safety, and practical applicability. Materials and Methods: All PICC insertions were performed at patients’ bedside by a trained surgeon using sterile technique. A single- or double-lumen PICC catheter was inserted under ultrasound guidance, magnetic tracking, and intracavitary ECG confirmation to secure optimal venous entry and accurate tip positioning. Results: A total of 28 PICC lines were successfully inserted in 26 oncologic patients. Two patients required catheter re-insertion, one following accidental removal and one due to infection. In 26 of 28 cases (92.9%), insertions were completed on the first attempt, while two cases required a second attempt. Insertion in the Green Zone per the ZIM classification was achieved in 26 of 28 cases (92.9%), and only two required insertions in the Yellow Zone. The basilic vein was chosen in 75% of patients. A total of 23 single-lumen and five double-lumen catheters were inserted. In terms of complications, four cases of systemic infection occurred more than 15 days after insertion and were not considered insertion-related; two patients developed localized edema requiring anticoagulation, and four catheter occlusions were managed conservatively. Conclusions: At-home PICC placement appears to be a feasible and clinically applicable approach when performed by qualified and credentialed professionals. These observations, derived from real-world clinical experience, suggest a potential role for this model in selected patient populations. Using proper sterile technique and real-time tip confirmation tools, this intervention may contribute to improved continuity of care and reduced hospital visits in selected patients. These observations suggest a potential role for expanding outpatient vascular access programs in selected patient populations.
Full article
(This article belongs to the Special Issue Advances in Clinical Nursing: Integrating Advanced Surgical and Medical Nursing for Enhanced Patient Outcomes)
►▼
Show Figures

Figure 1
Open AccessReview
Gambling Disorder as a Behaviorally Driven Systemic Medical Condition: From Reward Circuitry to Multi-System Morbidity
by
Martina Ballerio, Piercarlo Minoretti and Enzo Emanuele
Clin. Pract. 2026, 16(8), 137; https://doi.org/10.3390/clinpract16080137 - 26 Jul 2026
Abstract
►▼
Show Figures
Historically framed as a behavioral addiction, gambling disorder (GD) has had its somatic dimension neglected by standard clinical evaluation. This is a narrative, hypothesis-generating review focusing on the somatic aspects of GD. Cross-sectional and prospective evidence increasingly shows a somatic phenotype distributed across
[...] Read more.
Historically framed as a behavioral addiction, gambling disorder (GD) has had its somatic dimension neglected by standard clinical evaluation. This is a narrative, hypothesis-generating review focusing on the somatic aspects of GD. Cross-sectional and prospective evidence increasingly shows a somatic phenotype distributed across four axes: cardiovascular (hypertension, angina, stroke, acute stress-induced cardiac events), metabolic (obesity, type 2 diabetes, chronic liver disease), sleep-related (insomnia, poor sleep quality, daytime sleepiness), and—as an emerging and insufficiently characterized dimension—neurological (clustering with seizures and frontal lobe epilepsy). Three candidate biological systems may translate this exposure into multi-system physiology: (i) a hyperreactive mesostriatal reward circuit hypothesized to sustain a behavioral cluster of smoking, hazardous alcohol use, low physical activity, and unhealthy diet; (ii) an integrated stress response postulated to shift from acute hyperreactivity to chronic basal cortisol blunting and reduced vagal tone; and (iii) putative alterations in peripheral neurotrophic signaling and frontal-callosal structure, marked by elevated peripheral brain-derived neurotrophic factor and by frontal-callosal white-matter alterations—with cumulative allostatic load serving as a conceptual integrating frame. We propose that GD can be a behaviorally driven systemic medical condition, warranting internal medicine involvement alongside addiction psychiatry. Within this framework, glucagon-like peptide-1 receptor agonists emerge as an exploratory therapeutic hypothesis warranting dedicated evaluation in GD, given their action on the mesolimbic reward substrate and phase 3 evidence in adjacent cardiometabolic, hepatic, and sleep conditions.
Full article

Figure 1
Open AccessArticle
Nontherapeutic INR After Hospital Discharge: A Repeated-Measures Analysis of Warfarin-Treated Patients and Potential Drug–Drug Interactions
by
Kanthida Methaset, Pattamawan Kosuma and Arom Jedsadayanmata
Clin. Pract. 2026, 16(8), 136; https://doi.org/10.3390/clinpract16080136 - 25 Jul 2026
Abstract
Background: Warfarin remains widely used in specific clinical situations. Its management is complicated by multiple factors that affect anticoagulant response, particularly during the early period after hospital discharge. This study examined the prevalence, patterns, and factors associated with nontherapeutic international normalized ratio (INR)
[...] Read more.
Background: Warfarin remains widely used in specific clinical situations. Its management is complicated by multiple factors that affect anticoagulant response, particularly during the early period after hospital discharge. This study examined the prevalence, patterns, and factors associated with nontherapeutic international normalized ratio (INR) among patients discharged on warfarin from a tertiary-care hospital. Methods: Electronic health records of adult patients discharged home with warfarin who had at least one INR measurement within 90 days (N = 1222) were retrospectively analyzed. Nontherapeutic INR was defined as INR outside the therapeutic range: 2.5–3.5 for mitral valve replacement and 2.0–3.0 otherwise. All available INR measurements were included. Major warfarin potential drug–drug interactions (pDDIs) were defined as DDIs with major severity according to the Micromedex® database. Factors associated with nontherapeutic INR were examined using repeated-measures generalized estimating equations (GEEs), with generalized linear mixed models (GLMMs) as confirmatory analyses. Results: Of 3704 INR measurements within 90 days after discharge, 49.4% were subtherapeutic, while 30.5% were therapeutic and 20.1% were supratherapeutic. The proportion of therapeutic INR values did not show a substantial improvement over time. In GEEs, discharge from surgical service (adjusted odds ratio (aOR) 1.24, 95%CI: 1.05–1.48, p = 0.014) and presence of major warfarin pDDIs at discharge (aOR 1.36, 95%CI: 1.11–1.67, p = 0.003) were associated with nontherapeutic INR. GLMM analyses produced consistent results with the GEE model. Conclusions: Suboptimal INR control was prevalent within 90 days post-discharge. Discharge from surgical services and presence of major warfarin pDDIs at discharge were associated with nontherapeutic INRs. Major warfarin pDDIs may serve as markers of medication complexity at discharge and may help identify patients requiring closer anticoagulation monitoring.
Full article
(This article belongs to the Section Cardiac and Cardiovascular Systems)
►▼
Show Figures

Figure 1
Open AccessReview
Apert Syndrome: Oral, Maxillofacial and Dental Management—A Narrative Clinical Review
by
Nikolaos G. A. Kolomvos, Thomai Papadaki and Gregoris Venetis
Clin. Pract. 2026, 16(7), 135; https://doi.org/10.3390/clinpract16070135 - 22 Jul 2026
Abstract
Apert syndrome is a rare genetic disorder characterized by premature fusion of the cranial sutures, syndactyly of the extremities, and distinct craniofacial deformities. The condition results from mutations in the FGFR2 gene, which disrupt normal craniofacial growth and lead to complex functional and
[...] Read more.
Apert syndrome is a rare genetic disorder characterized by premature fusion of the cranial sutures, syndactyly of the extremities, and distinct craniofacial deformities. The condition results from mutations in the FGFR2 gene, which disrupt normal craniofacial growth and lead to complex functional and morphological abnormalities. Patients with Apert syndrome commonly present with stomatognathic abnormalities, which significantly affect oral function and facial development. The management of Apert syndrome requires a multidisciplinary therapeutic approach. Surgical treatment strategies are typically staged according to the patient’s age and clinical severity. Early interventions focus on cranial vault expansion procedures, such as fronto-orbital advancement and posterior vault distraction osteogenesis, aiming to relieve intracranial pressure and improve cranial morphology. During childhood and adolescence, midface advancement techniques are commonly performed to address midfacial hypoplasia and associated functional impairments. Early diagnosis and appropriate surgical planning play a crucial role in preventing complications and improving the functional, aesthetic, and psychosocial outcomes of patients with Apert syndrome. This narrative review summarizes current evidence while highlighting areas of ongoing controversy, particularly regarding surgical sequencing, orthodontic management and the integration of digital technologies into multidisciplinary care.
Full article
(This article belongs to the Special Issue Clinical Outcome Research in the Head and Neck: 2nd Edition)
Open AccessArticle
Healthcare Indicators in Lithuania: A Descriptive Analysis of Their Contextual Relevance to Health Literacy
by
Sonata Čerkauskaitė and Alina Liepinaitienė
Clin. Pract. 2026, 16(7), 134; https://doi.org/10.3390/clinpract16070134 - 17 Jul 2026
Abstract
►▼
Show Figures
Background/Objectives: Chronic non-communicable diseases remain one of the main public health problems. Increasing multimorbidity and the importance of health literacy (HL) emphasize the need for a comprehensive assessment of health indicators. The aim of this study was to assess the main health
[...] Read more.
Background/Objectives: Chronic non-communicable diseases remain one of the main public health problems. Increasing multimorbidity and the importance of health literacy (HL) emphasize the need for a comprehensive assessment of health indicators. The aim of this study was to assess the main health indicators of the Lithuanian population and trends in the use of healthcare services and to discuss the relevance of these indicators in the context of HL, based on the links between HL and these indicators described in the scientific literature. Methods: A retrospective longitudinal descriptive study was performed using publicly available Lithuanian population health statistics of 2005–2024. Mortality, morbidity, avoidable hospitalizations, subjective health assessment, and utilization of healthcare services and preventive programs were analyzed using descriptive statistical analysis. HL was not directly measured but was used as a conceptual framework for interpreting the findings. Results: In Lithuania, the highest mortality rate is due to cardiovascular diseases (CVDs) (~50.8%). CVD and infectious diseases also dominate the structure of avoidable hospitalizations, and their rates vary greatly across municipalities, being higher in less urbanized areas. The assessment of the population’s health is improving over time, but gender differences remain in the use of healthcare services and preventive programs. Conclusions: The findings demonstrate a high burden of chronic diseases and regional disparities in healthcare utilization in Lithuania. HL may provide a useful context for interpreting these findings, although it was not directly assessed. Future studies should directly evaluate HL and its association with health indicators in the Lithuanian population.
Full article

Figure 1
Open AccessArticle
Indications, Causes, and Patient Risk Factors for Revision After Total Ankle Arthroplasty: A Descriptive Cross-Registry Analysis of the NJR, AOANJRR, and SwedAnkle Registries
by
Sedeek Mosaid, Yousif Jihad, Mostafa Jihad, Ashok Marudanayagam and Paul Lee
Clin. Pract. 2026, 16(7), 133; https://doi.org/10.3390/clinpract16070133 - 17 Jul 2026
Abstract
►▼
Show Figures
Background/Objectives: Total ankle arthroplasty (TAA) is increasingly used to treat end-stage ankle arthritis, but comprehensive cross-registry data on revision patterns remain limited. This study describes indications, causes, and patient risk factors for revisions using three national registries. Methods: Aggregate data were extracted from
[...] Read more.
Background/Objectives: Total ankle arthroplasty (TAA) is increasingly used to treat end-stage ankle arthritis, but comprehensive cross-registry data on revision patterns remain limited. This study describes indications, causes, and patient risk factors for revisions using three national registries. Methods: Aggregate data were extracted from the UK National Joint Registry (NJR; 22nd Annual Report 2025; n = 11,321), the Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR; 2025 Ankle Supplementary Report; n = 5379), and the Swedish Ankle Registry (SwedAnkle; Annual Report 2024; n = 1852; survival estimates from a published sub-cohort, n = 1226). Metrics were compared descriptively without inferential pooling. Results: Across registries, 18,552 primary TAAs were identified. Ten-year cumulative per cent revision (CPR) was 9.54% (95% confidence interval [CI], 8.75–10.39) in the NJR, 13.5% (95% CI, 12.1–15.1) in the AOANJRR osteoarthritis sub-cohort, and approximately 26% (author-derived from Kaplan–Meier curves; see Methods) in SwedAnkle (1993 onwards implants). Aseptic loosening was the predominant cause of revision in all three registries; the rank of subsequent causes differed between registries (infection was second in the NJR and AOANJRR; in SwedAnkle, infection ranked below insert wear/breakage at 11.5%). AOANJRR Cox analysis identified younger age (hazard ratios (HRs), 2.00 for <55 vs. ≥75 years; 95% CI, 1.30–3.07; p = 0.001), earlier surgical era (HR, 1.91 for pre-2015 vs. 2015–2024; 95% CI, 1.53–2.38; p < 0.001), and obesity (HR, 1.52 for body mass index (BMI) ≥ 30; 95% CI, 1.06–2.19; p = 0.023) as significant independent predictors in AOANJRR Cox proportional hazards models (osteoarthritis sub-cohort for age, sex, BMI and ASA; all-diagnoses primary cohort for surgical era). Sex and American Society of Anesthesiologists (ASA) scores were not significant. Conclusions: Aseptic loosening was the predominant cause of revision in all three registries. The rank of subsequent causes differed: in the NJR and AOANJRR, infection was the second most frequent cause; in SwedAnkle, infection ranked below insert wear/breakage. Younger age, obesity, and earlier surgical era were independent predictors of revision in AOANJRR Cox proportional hazards models. The post-2015 era was associated with approximately 48% lower revision hazard; this association cannot be interpreted causally, as the independent contributions of implant design, surgical technique, patient selection, and other secular changes cannot be isolated from registry data. These findings may inform preoperative counselling, implant selection, and registry harmonisation efforts.
Full article

Figure 1
Open AccessArticle
Sonographic Assessment of Fetal Anatomy in the First Trimester: A Comparative Study of Visualization Rates Using Two- and Three-Dimensional Ultrasound
by
Savoia Fabiana, La Verde Marco, Giudicepietro Antonia, Minnella Gian Piero, Fantasia Ilaria, Sarno Laura, Quaresima Paola, Gerbino Martina, Volpe Grazia, Dall’Asta Andrea and Morlando Maddalena
Clin. Pract. 2026, 16(7), 132; https://doi.org/10.3390/clinpract16070132 - 15 Jul 2026
Abstract
Background/Objectives: This study aimed to compare the visualization rates of fetal anatomical structures with standard 2D ultrasound examination versus a single 3D volume acquired during the first trimester. Methods: This multicenter prospective study was performed in nine tertiary referral centers, by experienced
[...] Read more.
Background/Objectives: This study aimed to compare the visualization rates of fetal anatomical structures with standard 2D ultrasound examination versus a single 3D volume acquired during the first trimester. Methods: This multicenter prospective study was performed in nine tertiary referral centers, by experienced sonographers. A standard protocol was adopted in both 2D and 3D modalities to assess the 17 anatomical structures listed in the national and international guidelines. The included cases were non-anomalous fetuses from women booked for combined screening test between 11 + 0 and 13 + 6 weeks. Results: Two hundred and thirty-nine women were included in the study. The mean gestational age at ultrasound examination was 12 weeks ± 5 days (±5.4 SD). All the 17 structures were seen in 155/239 fetuses (64.85%) at 2D evaluation and in 84/239 (35.15%) at 3D evaluation (p = 0.001). Comparing 2D and 3D visualization, the following anatomical structures showed a statistical difference: posterior fossa (92% vs. 74%, p < 0.005); neck (94.2% vs. 87.2%, p < 0.001); orbits (93% vs. 85.6%, p < 0.001); nasal bone (93% vs. 88.8%, p = 0.016); lung fields (99.5% vs 96.7%, p = 0.046); cardiac axis (99.5% vs. 83.9%; p < 0.001); bladder (97.5% vs. 91.7%, p < 0.001); abdominal wall (98.7% vs. 94.2%, p < 0.001). For the other anatomical portion, no statistically significant differences were found. Conclusions: Our study demonstrates that a full assessment of fetal anatomy is best performed using 2D ultrasound, while 3D ultrasound showed lower overall visualization rates, with comparable performance for selected structures, suggesting a potential supplementary use in specific clinical contexts.
Full article
(This article belongs to the Section Reproductive Medicine and Women’s Health)
Open AccessArticle
Early Risk Stratification of Delirium in Intermediate Care Units and Its Impact on 30-Day Mortality: A Decision-Tree Analysis
by
Fabrizio Lucente, Lucia Filippi, Arian Zaboli, Alessandra Eugenia Bionda, Michael Maggi, Marta Parodi, Alice Bresolin, Arianna Pretto, Martina Da Meda, Silvia Greselin, Francesca Fulghesu and Gianni Turcato
Clin. Pract. 2026, 16(7), 131; https://doi.org/10.3390/clinpract16070131 - 13 Jul 2026
Abstract
►▼
Show Figures
Background: Delirium is an under-recognized complication in hospitalized acute care patients, associated with worse outcomes including increased length of stay, higher ICU admission rates and greater mortality. Although screening tools exist for early diagnosis, the absence of admission-based tools limits early risk stratification
[...] Read more.
Background: Delirium is an under-recognized complication in hospitalized acute care patients, associated with worse outcomes including increased length of stay, higher ICU admission rates and greater mortality. Although screening tools exist for early diagnosis, the absence of admission-based tools limits early risk stratification and timely prevention strategies. Aim: To identify early risk factors for delirium development in IMCU patients and quantify its prognostic role on 30-day mortality. Methods: In this prospective single-center study, 651 consecutive IMCU patients without delirium at admission were enrolled. Admission variables were analyzed using multivariable logistic regression and Classification and Regression Tree (CART) analysis to identify clinically relevant risk phenotypes. The association between delirium and 30-day mortality was assessed in adjusted models. Results: Delirium developed in 18.6% of patients within 96 h. Key independent risk factors included age (OR 1.04), male sex (OR 1.75), alcohol use disorder (OR 3.59), cognitive impairment (OR 3.35), COPD (OR 1.68), NEWS (OR 1.18), and need for NIV (OR 3.83). CART analysis identified NIV as the dominant early discriminator, followed by cognitive vulnerability and acute severity. 30-day mortality was significantly higher in patients with delirium (22.3% vs. 9.8%, p = 0.001). Delirium remained an independent risk factor after adjustment (OR 2.53). CART analysis further corroborates delirium as a significant determinant, enhancing prognostic stratification beyond its role as a mere surrogate of disease severity. Conclusions: Admission-level clinical variables and exploratory CART analysis identified clinically interpretable delirium risk phenotypes in IMCU patients. Delirium was independently associated with increased 30-day mortality. These findings provide a preliminary framework for future validation studies and development of IMCU-specific risk-stratification approaches.
Full article

Graphical abstract
Journal Menu
► ▼ Journal Menu-
- Clinics and Practice Home
- Aims & Scope
- Editorial Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserHighly Accessed Articles
Latest Books
E-Mail Alert
News
15 May 2026
Nutrients 2026—Clinical Nutrition: From Research to Practice—Submission Deadline Extended
Nutrients 2026—Clinical Nutrition: From Research to Practice—Submission Deadline Extended
13 August 2026
Meet Us at the IASLC 2026 World Conference on Lung Cancer, 12–15 September 2026, Seoul, Republic of Korea
Meet Us at the IASLC 2026 World Conference on Lung Cancer, 12–15 September 2026, Seoul, Republic of Korea
Topics
Topic in
Biomedicines, Clinics and Practice, Diagnostics, JCM, Rheumato
Rheumatic Disorder: From Basic Science to Clinical Practice—2nd Edition
Topic Editors: Andreina Manfredi, Caterina Vacchi, Giulia CassoneDeadline: 20 September 2026
Topic in
JCM, Medicina, Prosthesis, IJMS, Clinics and Practice
Innovations in Plastic Surgery and Regenerative Medicine—2nd Edition
Topic Editors: Francesco D’Andrea, Jean Paul Meningaud, Barbara Hersant, Simone La PadulaDeadline: 30 November 2026
Topic in
Brain Sciences, Children, Foods, Geriatrics, Nutrients, Clinics and Practice, Dietetics, JGG
Lifestyle, Health and Mental Well-Being Across the Lifespan
Topic Editors: Tonia Vassilakou, Rena I. Kosti, Maria G. GrammatikopoulouDeadline: 31 December 2026
Topic in
Biomechanics, Clinics and Practice, JFMK, Medicina, Sports
Biomechanics, Rehabilitation, and Metabolic Health: The Role of Physical Activity in Managing Chronic Conditions
Topic Editors: Jan Bilski, Nicola Luigi BragazziDeadline: 28 February 2027
Conferences
Special Issues
Special Issue in
Clinics and Practice
Advances in Thromboembolism: Precision Prevention and Clinical Management
Guest Editors: Anabel Isabel Franco-Moreno, Cristina Lucía de Ancos AracilDeadline: 31 August 2026
Special Issue in
Clinics and Practice
Exercise and Sports for Chronic Diseases
Guest Editor: Giacomo FarìDeadline: 31 August 2026
Special Issue in
Clinics and Practice
Advances in Clinical Nursing: Integrating Advanced Surgical and Medical Nursing for Enhanced Patient Outcomes
Guest Editor: Georgios VasilopoulosDeadline: 30 September 2026
Special Issue in
Clinics and Practice
Advances in Rheumatology: Innovations in Diagnosis, Treatment and Personalized Care
Guest Editor: Hideyuki IwaiDeadline: 30 September 2026


